SenzaGen: Q1 Initial take – Sales a bit lower than estimated - Redeye

Redeye provides an initial take following the release of SenzaGen’s Q1 2025 report. The quarterly sales came in a bit lower than expected; however, operating expenses were a bit better than anticipated. We will provide a research update shortly, where we will dig deeper into the report, likely making some downward changes to our short-term sales estimates.

Länk till analysen i sin helhet: https://www.redeye.se/research/1108241/senzagen-q1-initial-take-sales-a-bit-lower-than-estimated?utm_source=finwire&utm_medium=RSS